Upper GI symptoms (n = 13,389) | Control patients (n = 13,389) | Odds ratio (95% CI) | |
---|---|---|---|
Alimentary tract and metabolism | 92.5 | 17.3 | 59.1 (54.7-63.9) |
Excluding drugs for acid related disorders (A02†) | 32.3 | 14.1 | 2.90 (2.73-3.08) |
Blood | 18.5 | 13.2 | 1.50 (1.40-1.60) |
Cardiovascular system | 34.2 | 25.6 | 1.51 (1.44-1.59) |
Dermatologicals | 32.8 | 21.4 | 1.79 (1.70-1.89) |
Genito-urinary system and sex hormones | 20.4 | 15.6 | 1.39 (1.31-1.48) |
Systemic hormonal preparations excluding insulin | 10.0 | 6.6 | 1.59 (1.45-1.73) |
Anti-infectives ‡ | 42.1 | 30.5 | 1.66 (1.58-1.74) |
Antineoplastic and immunomodulating agents | 1.1 | 0.8 | 1.44 (1.12-1.85) |
Musculoskeletal system | 33.9 | 21.6 | 1.86 (1.76-1.96) |
NSAIDs* (M01A†) | 31.5 | 20.0 | 1.83 (1.73-1.94) |
Nervous system | 45.1 | 26.0 | 2.34 (2.22-2.46) |
Antiparasitic products, insecticides, repellents | 1.9 | 1.0 | 1.97 (1.59-2.43) |
Respiratory system | 32.1 | 20.4 | 1.84 (1.74-1.95) |
Sensory organs | 14.8 | 10.1 | 1.55 (1.44-1.67) |
Various | 0.2 | 0.1 | 1.93 (1.01-3.68) |